AstraZeneca prices a $7bn bond offering
26 May 2021 07:00 BST AstraZeneca prices a $7bn bond offering AstraZeneca PLC ("AstraZeneca") announces that it, and its wholly owned subsidiary AstraZeneca Finance LLC, priced a six tranche global bond offering totalling $7bn on 25 May 2021. The offering is expected to close on 28 May 2021, subject to customary closing conditions. The transaction, which is a global offering registered with the US Securities and Exchange Commission ("SEC"), consists of the following six tranches: Notes issued by AstraZeneca · $1.40bn of fixed rate notes with a coupon of 0.300%, maturing 26